Anna Pawełczyk

403 total citations
33 papers, 293 citations indexed

About

Anna Pawełczyk is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Anna Pawełczyk has authored 33 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 11 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Anna Pawełczyk's work include Synthesis and biological activity (10 papers), Natural product bioactivities and synthesis (5 papers) and Synthesis and Biological Evaluation (5 papers). Anna Pawełczyk is often cited by papers focused on Synthesis and biological activity (10 papers), Natural product bioactivities and synthesis (5 papers) and Synthesis and Biological Evaluation (5 papers). Anna Pawełczyk collaborates with scholars based in Poland, Ukraine and Russia. Anna Pawełczyk's co-authors include Lucjusz Zaprutko, Dorota Olender, Hanna Piotrowska‐Kempisty, Małgorzata Józkowiak, Roman Lesyk, Anna Jelińska, Andrzej Gzella, Konrad A. Szychowski, Bartosz Skóra and Jacek Kujawski and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and RSC Advances.

In The Last Decade

Anna Pawełczyk

29 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Pawełczyk Poland 10 132 89 24 24 21 33 293
Omnia M. Hendawy Saudi Arabia 12 157 1.2× 104 1.2× 21 0.9× 30 1.3× 26 1.2× 21 337
Sonali S. Kamble India 10 171 1.3× 92 1.0× 31 1.3× 33 1.4× 25 1.2× 17 337
Nirmal Kumar Kasinathan India 9 88 0.7× 111 1.2× 26 1.1× 35 1.5× 16 0.8× 12 310
Mohammed Faiz Arshad Saudi Arabia 8 129 1.0× 85 1.0× 22 0.9× 40 1.7× 27 1.3× 12 351
Amalia Ștefaniu Romania 10 86 0.7× 70 0.8× 17 0.7× 23 1.0× 35 1.7× 40 305
Saba Farooq Malaysia 9 214 1.6× 69 0.8× 27 1.1× 35 1.5× 35 1.7× 35 344
Rakesh R. Somani India 12 188 1.4× 146 1.6× 35 1.5× 31 1.3× 25 1.2× 43 412
Bhoomendra A. Bhongade United Arab Emirates 10 191 1.4× 118 1.3× 37 1.5× 22 0.9× 40 1.9× 32 379
Dorota Olender Poland 9 217 1.6× 115 1.3× 27 1.1× 16 0.7× 18 0.9× 22 346
Khursheed Ahmed India 11 150 1.1× 72 0.8× 33 1.4× 29 1.2× 28 1.3× 57 322

Countries citing papers authored by Anna Pawełczyk

Since Specialization
Citations

This map shows the geographic impact of Anna Pawełczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Pawełczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Pawełczyk more than expected).

Fields of papers citing papers by Anna Pawełczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Pawełczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Pawełczyk. The network helps show where Anna Pawełczyk may publish in the future.

Co-authorship network of co-authors of Anna Pawełczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Pawełczyk. A scholar is included among the top collaborators of Anna Pawełczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Pawełczyk. Anna Pawełczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zaprutko, Lucjusz, et al.. (2025). FDA-approved kinase inhibitors in PROTAC design, development and synthesis. Journal of Enzyme Inhibition and Medicinal Chemistry. 40(1). 2542357–2542357. 2 indexed citations
3.
5.
Lesyk, Roman, et al.. (2024). IR-EcoSpectra: Exploring sustainable ex situ and in situ FTIR applications for green chemical and pharmaceutical analysis. Journal of Pharmaceutical Analysis. 14(9). 100951–100951. 13 indexed citations
6.
Olender, Dorota, Jacek Kujawski, Bartosz Skóra, et al.. (2024). Bis-chalcones obtained via one-pot synthesis as the anti-neurodegenerative agents and their effect on the HT-22 cell line. Heliyon. 10(17). e37147–e37147. 2 indexed citations
7.
Józkowiak, Małgorzata, et al.. (2023). Curcumin–Triterpene Type Hybrid as Effective Sonosensitizers for Sonodynamic Therapy in Oral Squamous Cell Carcinoma. Pharmaceutics. 15(7). 2008–2008. 5 indexed citations
8.
Olender, Dorota, et al.. (2023). Curcuminoid Chalcones: Synthesis and Biological Activity against theHuman Colon Carcinoma (Caco-2) Cell Line. Current Medicinal Chemistry. 31(33). 5397–5416. 4 indexed citations
9.
Olender, Dorota, et al.. (2023). Synthesis of curcumin derivatives containing non-steroidal anti-inflammatory drugs. Acta Poloniae Pharmaceutica - Drug Research. 80(2). 289–304. 1 indexed citations
10.
Totoń, Ewa, Jacek Kujawski, Dorota Olender, et al.. (2023). Synthesis, Cytotoxicity and Molecular Docking of New Hybrid Compounds by Combination of Curcumin with Oleanolic Acid. Biomedicines. 11(6). 1506–1506. 2 indexed citations
11.
Pawełczyk, Anna, et al.. (2023). Genistein - characterization of the molecule, similarity to estradiol and pharmacological potential. Acta Poloniae Pharmaceutica - Drug Research. 80(2). 193–205. 1 indexed citations
12.
Pawełczyk, Anna, et al.. (2023). Novel Molecular Consortia of Cannabidiol with Nonsteroidal Anti-Inflammatory Drugs Inhibit Emerging Coronaviruses’ Entry. Pathogens. 12(7). 951–951. 2 indexed citations
13.
Kryshchyshyn‐Dylevych, Anna, Nataliya Finiuk, Lidia Radko, et al.. (2022). Anticancer cytotoxicity of indole-thiazolidinone hybrids, in silico study of mechanisms of their action. Biopolymers and Cell. 38(4). 257–277. 1 indexed citations
14.
Piotrowska‐Kempisty, Hanna, et al.. (2022). Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods. European Journal of Pharmaceutical Sciences. 171. 106133–106133. 17 indexed citations
15.
Pawełczyk, Anna, et al.. (2022). Antimicrobial and Odour Qualities of Alkylpyrazines Occurring in Chocolate and Cocoa Products. Applied Sciences. 12(22). 11361–11361. 17 indexed citations
16.
Pawełczyk, Anna, et al.. (2020). Linked drug-drug conjugates based on triterpene and phenol structures. Rational synthesis, molecular properties, toxicity and bioactivity prediction. Arabian Journal of Chemistry. 13(12). 8793–8806. 9 indexed citations
17.
Pawełczyk, Anna, et al.. (2018). Molecular Consortia—Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis. International Journal of Molecular Sciences. 19(4). 1104–1104. 61 indexed citations
18.
Pawełczyk, Anna, et al.. (2016). Hybrid Compounds Strategy in the Synthesis of Oleanolic Acid Skeleton-NSAID Derivatives. Molecules. 21(4). 420–420. 19 indexed citations
19.
Pawełczyk, Anna & Lucjusz Zaprutko. (2010). Synthesis of fragrant heterocyclic thioketo analogues of jasmone under microwave conditions. Flavour and Fragrance Journal. 26(2). 101–106. 4 indexed citations
20.
Pawełczyk, Anna & Lucjusz Zaprutko. (2006). Microwave assisted synthesis of fragrant jasmone heterocyclic analogues. European Journal of Medicinal Chemistry. 41(5). 586–591. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026